Home / About Novasep / Media & Events / Articles and publications / Continuous progress: the rise of continuous chromatography in biopharmaceutical processing

Continuous progress: the rise of continuous chromatography in biopharmaceutical processing

15 Mar 2014

Continuous processing is gaining interest in biopharmaceutical industry due to traditional justifications (such as higher productivity and lower costs) as well as its ability to address biopharmaceutical specificities. Continuous chromatography has been in use since the 1960s and has progressed across industries by capitalising on its previous applications, leading each time to major innovations. The successful implementation of continuous chromatography in the pharmaceutical industry in the 90s for the purification of small molecule APIs demonstrated the importance of technological expertise and mastery of regulatory aspects. As a result, several commercial processes have been approved and the technology remains an industrial standard. Biopharmaceutical industry is about to experience the same evolution. To succeed, proven understanding and experience in implementing continuous chromatography at an industrial scale will be key factors.

Download the document: Novasep Icon PDF

Innovations in Pharmaceutical Technology, March 2014

Authors: Dr. Fabien Rousset, Nicolas-Julian Hilbold


Back to full list of events

You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!